Is there a gender effect in bladder cancer? A population-based study of practice and outcomes

Journal of the Canadian Urological Association

Volumn 9, Issue 7-8 August, 2015, Pages 269-274

  Patafio, Francis Michael ^a   Siemens, D Robert ^a,b   Wei, Xuejiao ^a   Booth, Christopher M ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84939559923     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.2927     Document Type: Article

References (27)

1. Statistics CCSACOC. Canadian Cancer Statistics 2014. Canadian Cancer Society 2014:1-132.
2. Castelao JE, Yuan JM, Skipper PL, et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93:538-45. http://dx.doi.org/10.1093/jnci/93J.538
3. Freedman ND, Silverman DT, Hollenbeck AR, et al. Association between smoking and risk of bladder cancer among men and women. JAMA 2011;306:737-45. http://dx.doi.org/10.1001/jama.2011.1142
4. Gaertner RRW, Trpeski L, Johnson KC. Canadian Cancer Registries Epidemiology Research Group. A case-control study of occupational risk factors for bladder cancer in Canada. Cancer Causes Control 2004;15:1007-19. http://dx.doi.org/10.1007/s10552-004-1448-7
5. Miyamoto H, Yang Z, Chen Y-T, et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007;99:558-68. http://dx.doi.org/10.1093/jnci/djk113
6. Cardenas-Turanzas M, Cooksley C, Pettaway CA, et al. Comparative outcomes of bladder cancer. Obstet Gynecol 2006;108:169-75. http://dx.doi.org/10.1097/01.AOG.0000223885.25192.91
7. Underwood W, Dunn RL, Williams C, et al. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg 2006;202:284-90. http://dx.doi.org/10.1016/Zj.jamcollsurg.2005.09.009
8. Fleshner NE, Herr HW, Stewart AK, et al. The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1996;78:1505-13. http://dx.doi.org/10.1002/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3
9. Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000;55:876-80. http://dx.doi.org/10.1016/S0090-4295(00)00523-9
10. Koch M, McPhee MS, Gaedke H, et al. Five year follow-up of patients with cancer of the bladder-the Northern Alberta experience. Clin Invest Med 1988;1 1:253-8.
11. Johnson EK, Daignault S, Zhang Y, et al. Patterns of hematuria referral to urologists: Does a gender disparity exist? Urology 2008;72:498-502. http://dx.doi.org/10.1016/j.urology.2008.01.086
12. May M, Stief C, Brookman-May S, et al. Gender-dependent cancer-specific survival following radical cystectomy. World J Urol 2011;30:707-13. http://dx.doi.org/10.1007/s00345-011-0773-1
13. Booth CM, Siemens DR, Li G, et al. Curative therapy for bladder cancer in routine clinical practice: A population-based outcomes study. Clin Oncol (R Coll Radiol). 2014;26:506-14. http://dx.doi. org/10.1016/j.clon.2014.05.007
14. Booth CM, Siemens DR, Li G, et al. Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study. Cancer 2014;120:1630-8. http://dx.doi.org/10.1002/cncr.28510
15. Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: A computer approach. IARC Sci Publ 1991:246-57.
16. Boyd C, Zhang-Salomons JY, Groome PA, et al. Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol 1999;17:2244-55.
17. Goel V. The ICES Practice Atlas. 2nd ed. Ottawa, ON: Canadian Medical Association; 1996.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9. http://dx.doi.org/10.1016/0895-4356(92)90133-8
19. Kankesan J, Shepherd FA, Peng Y, et al. Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: A population-based study. Curr Oncol 2013;20:30-7. http://dx.doi.org/10.3747/co.20.1178
20. Booth CM, Siemens DR, Peng Y, et al. Patterns of referral for perioperative chemotherapy among patients with muscle-invasive bladder cancer: A population-based study. Urol Oncol 2014;32:1200-8. http://dx.doi.org/10.1016/j.urolonc.2014.05.012
21. Micheli A, Mariotto A, Giorgi Rossi A, et al. The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. Eur J Cancer 1998;34:2271-8.
22. Schrag D, Mitra N, Xu F, et al. Cystectomy for muscle-invasive bladder cancer: Patterns and outcomes of care in the medicare population. Urology 2005;65:1118-25. http://dx.doi.org/10.1016/j.urol-ogy.2004.12.029
23. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: An analysis of data from the SEER program. J Urol 2003;170:1765-71. http://dx.doi.org/10.1097/01.ju.0000091620.86778.2e
24. Hsu J-W, Hsu I, Xu D, et al. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. Am J Pathol 2013;182:1811-20. http://dx.doi.org/10.1016/j.ajpath.2013.01.018
25. Izumi K, Taguri M, Miyamoto H, et al. Androgen deprivation therapy prevents bladder cancer recurrence. Oncotarget 2014;5:12665-74.
26. Booth CM, Tannock IF. Randomised controlled trials and population-based observational research: Partners in the evolution of medical evidence. Br J Cancer 2014;110:551-5. http://dx.doi.org/10.1038/bjc.2013.725
27. Booth CM, Mackillop WJ. Translating new medical therapies into societal benefit: The role of population-based outcome studies. JAMA 2008;300:2177-9. http://dx.doi.org/10.1001/jama.300.18.2177